Dexcom Inc (DXCM)

$127.07 10.94 (7.93%)

13:34 EDT DXCM Stock Quote Delayed 30 Minutes

DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 25, 2024

DXCM stock results show that DexCom beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

Volume:

Previous Close -

Market Cap 12.29B

PE Ratio 97.75

EPS 1.3

Volume (Avg. Vol.) 5.11M

Day's Range $126.68 - $138.81

52-Week Range $74.75 - $142.00

Dividend & Yield N/A (N/A)

DXCM Stock Predictions, Articles, and Dexcom Inc News

From InvestorPlace
From the Web

7 Nasdaq Stocks to Sell in April Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor Apr 3, 2024

The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late.

3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List

By Will Ashworth, InvestorPlace Contributor Apr 1, 2024

The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’

By Rich Duprey, InvestorPlace Contributor Mar 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

3 Telehealth Stocks With Room to Run in 2024

By Muslim Farooque, InvestorPlace Contributor Feb 29, 2024

Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Mid-Cap Stocks Poised for a Breakout in 2024

By Alex Sirois, InvestorPlace Contributor Jan 16, 2024

Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.

The 3 Best Growth Stocks to Buy in January 2024

By Charles Munyi, InvestorPlace Contributor Jan 14, 2024

The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth.

3 Stocks to Capitalize on the Telehealth Explosion

By Ian Bezek, InvestorPlace Contributor Jan 8, 2024

These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.

3 Earnings Winners Poised to Outperform the Market

By Rick Orford, InvestorPlace Contributor Nov 9, 2023

Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio?

3 Healthcare Stocks Getting Help From the Aging Population

By Larry Ramer, InvestorPlace Contributor Nov 6, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

The 7 Best Nasdaq Stocks To Buy Now: October 2023

By Alex Sirois, InvestorPlace Contributor Oct 19, 2023

The best Nasdaq stocks go much deeper than the magnificent 7 and offer surprising stability in addition to broad exposure to AI.

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

By Larry Ramer, InvestorPlace Contributor Oct 4, 2023

Diabetes stocks have retreated excessively on the belief that a new weight-loss drug will greatly reduce the number of diabetes patients.

3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall

By Will Ashworth, InvestorPlace Contributor Sep 23, 2023

Nonetheless, if you can only have one sector ETF in your investment portfolio, it should be healthcare

3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought

By Rich Duprey, InvestorPlace Contributor Sep 21, 2023

Yet just as quickly, it made a U-turn and more than doubled again over the next 18 months.

7 Top Stock Opportunities on the Heels of the Latest Jobs Report

By Alex Sirois, InvestorPlace Contributor Aug 20, 2023

These 7 stocks to buy for the jobs report look to be in strong position as the economy cools and inflation slides.

What Are the Best Companies to Invest in Now? Our 3 Picks for August

By Michael Que, InvestorPlace Contributor Aug 10, 2023

After you after the best companies to invest in? Here are the best picks for the month of August that you can't afford to miss.

3 HealthTech Stocks to Watch as Digital Health Transforms the Industry

By Larry Ramer, InvestorPlace Contributor May 4, 2023

Healthtech is a large and growing field. These are three of the best healthtech stocks to buy for innovation-oriented investors right now.

The Top 7 “Millionaire-Maker” Long-Term Stocks for 2023

By Joel Baglole, InvestorPlace Contributor Jan 19, 2023

Study after study shows that a long-term buy-and-hold investing strategy works best. A long-term investment is generally defined as any position in a stock that is held for a year or longer. While the stock market can decline by 20% or more in a year, as was the case in 2022, equities almost always rise over the long term.

3 No-Brainer Growth Stocks to Buy for 2023 and Beyond

By Will Ashworth, InvestorPlace Contributor Nov 11, 2022

No-brainer growth stocks to buy for 2023 and beyond are companies that are growing their top and bottom lines and piling up the cash.

Dexcom Inc (DXCM)

DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Dexcom Inc (DXCM)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DXCM Stock Predictions, Articles, and Dexcom Inc News

Subscriber Sign in